Comment
doi: 10.1038/d41586-021-01392-2.
Count the cost of disability caused by COVID-19
- PMID: 34040204
- DOI: 10.1038/d41586-021-01392-2
Item in Clipboard
Comment
Count the cost of disability caused by COVID-19
Nature.
2021 May.
No abstract available
Keywords: Developing world; Economics; Health care; Public health; SARS-CoV-2; Vaccines.
Comment on
-
Will COVID force public health to confront America's epic inequality?Nature. 2021 Apr;592(7856):674-680. doi: 10.1038/d41586-021-00943-x. Nature. 2021. PMID: 33911280 No abstract available.
Similar articles
-
Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol.BMJ Open. 2021 Aug 20;11(8):e052282. doi: 10.1136/bmjopen-2021-052282. BMJ Open. 2021. PMID: 34417219 Free PMC article.
-
Impact of mRNA vaccines in curtailing SARS-CoV-2 infection and disability leave utilisation among healthcare workers during the COVID-19 pandemic: cross-sectional analysis from a tertiary healthcare system in the Greater Houston metropolitan area.BMJ Open. 2021 Oct 12;11(10):e054332. doi: 10.1136/bmjopen-2021-054332. BMJ Open. 2021. PMID: 34642201 Free PMC article.
-
Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.BMJ Open. 2022 Jan 3;12(1):e057127. doi: 10.1136/bmjopen-2021-057127. BMJ Open. 2022. PMID: 34980631 Free PMC article.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects.Rev Med Virol. 2021 Mar;31(2):e2168. doi: 10.1002/rmv.2168. Epub 2020 Sep 16. Rev Med Virol. 2021. PMID: 35349206 Review.
Cited by
-
Acceptability and feasibility of a theatre-based wellness programme to support people living with long COVID: a single-arm feasibility study.BMJ Open. 2024 Jul 1;14(6):e083224. doi: 10.1136/bmjopen-2023-083224. BMJ Open. 2024. PMID: 38951002 Free PMC article.
-
Youth Caregivers of Adults in the United States: Prevalence and the Association Between Caregiving and Education.Demography. 2024 Jun 1;61(3):829-847. doi: 10.1215/00703370-11383976. Demography. 2024. PMID: 38785364 Free PMC article.
-
Transition beyond the acute phase of the COVID-19 pandemic: Need to address the long-term health impacts of COVID-19.World J Clin Cases. 2022 Sep 26;10(27):9967-9969. doi: 10.12998/wjcc.v10.i27.9967. World J Clin Cases. 2022. PMID: 36186173 Free PMC article.
-
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.Nat Commun. 2021 Oct 29;12(1):6238. doi: 10.1038/s41467-021-26557-5. Nat Commun. 2021. PMID: 34716349 Free PMC article.
-
Health-related quality of life and QALY loss under COVID-19 lockdown: The case of Spain.PLoS One. 2025 Aug 7;20(8):e0329413. doi: 10.1371/journal.pone.0329413. eCollection 2025. PLoS One. 2025. PMID: 40773457 Free PMC article.
References
-
- PHOSP-COVID Collaborative Group. Preprint at medRxiv https://doi.org/10.1101/2021.03.22.21254057 (2021).
-
- Al-Aly, Z., Xie, Y. & Bowe, B. Nature https://doi.org/10.1038/s41586-021-03553-9 (2021). - PubMed
-
- National Institute for Health Research. Living with COVID19: Second Review https://doi.org/10.3310/themedreview_45225 (NIHR, 2021).
-
- Public Health England. Disparities in the Risk and Outcomes of COVID-19 (PHE, 2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
